ACS Clinical Research Program
Limited resection as a cure for early lung cancer: Time to challenge the gold standard?(Comments Off)
A clinical trial is exploring whether limited resection should replace lobectomy as the gold standard for treatment of early-stage lung cancer.
The PROSPECT trial for individualized treatment is discussed in this month’s column as is the surgeon’s role in ensuring the success of this trial.
Advances in the treatment of metastatic colorectal cancer have led to greatly improved survival rates, especially for patients with liver-only disease. These new approaches have increased the role of surgeons in the management of these patients.
Deficits in perioperative quality of life and rehabilitation programs are described in this article, as are practical interventions for integrating the patient’s perspective into care management.
The past decade has seen a paradigm shift in the treatment of men with advanced prostate cancer, according to the authors of this month column, a result of improved understanding of disease biology, investment in basic research and identification of rational therapeutic targets, collaboration with industry, and design and completion of well-designed clinical trials.
More in this category
- NCDB and ACS-CRP: Working together to develop risk-stratified strategies for surveillance
- SLN surgery for clinically node-positive breast cancer patients treated with neoadjuvant therapy
- Neoadjuvant cancer therapy: Benefitting patients and improving cancer care
- Patient quality of life: Vitally important
- Community-based physicians and hospitals need to participate in clinical trials
- Less invasive option for small hepatocellular carcinoma: Thermal ablation as first-line therapy?
- Patient-centered outcomes research: Is this really something new?
- Does altering diet affect progression of prostate cancer? The MEAL study
- American College of Surgeons Commission on Cancer Rapid Quality Reporting System: From quality measurement to quality improvement
- Improving cancer care through quality measures: Putting evidence to work with the CoC
- What is the appropriate extent of lymphadenectomy for bladder cancer?
- Are older adults adequately represented in surgical oncology trials?
- Borderline resectable pancreatic cancer: Pushing the technical limits of surgery
- Multiple ipsilateral breast cancers: Can the breast be preserved?
- Malignant pleural effusion research provides insights to improve surgical study design